小分子ACC抑制剂的发现:对过度的脂质分泌的潜在治疗方法
Xilong Feng1, Xinyu Luo1, Xiaotian Niu1
1School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, PR China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, 311121, PR China.
Bioorganic chemistry
|April 9, 2025
概括
抑制脂生产中的关键酶 - - 乙-甲氧酶,为治疗等皮肤疾病提供了一个有前途的策略. 本综述探讨了ACC抑制剂用于减少脂质的作用.
科学领域:
- 生物化学 生物化学
- 皮肤病学 皮肤病学
- 药用化学 医学化学
背景情况:
- 脂质过度产生的皮肤问题,如和脂质性皮肤炎.
- 乙-CoA碳氧酶 (ACC) 对于乳脂的新合成至关重要.
- 向ACC是一种可行的治疗方法,用于管理与皮脂相关的皮肤疾病.
研究的目的:
- 为了审查皮脂的新合成.
- 讨论乙烯基-CoA碳氧化酶 (ACC) 的异型,功能和催化机制.
- 提供ACC抑制剂的最新进展及其结构-活性关系的概述.
主要方法:
- 关于 de novo 皮脂合成的文献综述.
- 乙-CoA碳氧酶 (ACC) 结构和功能的分析.
- 在过去15年中开发的小分子ACC抑制剂的调查.
主要成果:
- 详细描述了皮脂合成途径.
- 关于ACC酶特性的全面概述.
- 各种ACC抑制剂的结构-活性关系的总结.
结论:
- 抑制乙烯基-CoA碳酸酶 (ACC) 是一种有效的策略来减少皮脂的产量.
- 小分子抑制剂的ACC显示治疗潜力和斑疹性皮肤炎.
- 对ACC抑制剂的持续研究可能会为皮肤疾病提供新的治疗方法.
相关概念视频
01:24Glucagon-like Receptor Agonists
272
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
272
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
646
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
646
01:19Antiasthma Drugs: Leukotriene Modifiers
172
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
172